| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 118 |
| 1 | OXYCODONE HYDROCHLORIDE | 52 |
| 2 | RISANKIZUMAB-RZAA | 45 |
| 3 | DUPILUMAB | 42 |
| 4 | INFLIXIMAB | 38 |
| 5 | SECUKINUMAB | 35 |
| 6 | UPADACITINIB | 32 |
| 7 | MYCOPHENOLATE MOFETIL | 28 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 28 |
| 9 | USTEKINUMAB | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SALICYLIC ACID 12% | 4 | 0.0021 |
| 1 | ASTRINGENT | 4 | 0.0021 |
| 2 | LIQUID CORN AND CALLUS REMOVER | 4 | 0.0021 |
| 3 | INFLIXIMAB-DYYB | 7 | 0.0020 |
| 4 | BRODALUMAB | 4 | 0.0019 |
| 5 | RISDIPLAM | 8 | 0.0019 |
| 6 | VELAGLUCERASE ALFA | 3 | 0.0015 |
| 7 | BEDAQUILINE FUMARATE | 2 | 0.0014 |
| 8 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 2 | 0.0012 |
| 9 | GOLIMUMAB | 15 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 4 | 0.0019 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 8 | 0.0019 |
| 2 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 3 | Interleukin-17A Antagonist [EPC] | 40 | 0.0011 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 8 | 0.0008 |
| 5 | Interleukin-23 Antagonist [EPC] | 83 | 0.0008 |
| 6 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 9 | Gonadotropin [EPC] | 1 | 0.0005 |